Closer to Truth brings together leading scientists, scholars and artists to debate the fundamental issues of our times.  Instituted in the sixties, clinical drug trials today have become a vast and expensive enterprise in which drug companies can spend over $100 million to bring a new molecule to market. FDA procedures are complex and elaborate as they should be, in order to bring new drugs to market quickly to help people in need, but to do good science to protect the public from a drug’s potentially dangerous side effects. Joining Robert Kuhn are Alexander Capron, Professor of Law and Medicine, USC; Andrea Kovacs, Director, HIV Family Clinic, USC; and Robert Temple, Associate Director, Medical Policy, FDA. From the Series:USC Presents...Closer To Truth